Transformative Biotech Purchases Direct-to-PCR Technologies From Summit Biolabs
May 19, 2023
Market-proven technologies in this intellectual property transaction offers many advantages over traditional PCR testing. BOULDER, Colo., May 18, 2023 /PRNewswire/ -- Transformative Biotech, LLC, announced its acquisition of Summit Biolabs' industry-leading, patent-pending technologies for extraction-free/direct-to-PCR testing on May 10, 2023. With the asset purchase now complete, Transformative Biotech's team will immediately work to broaden the adoption of these [...]
GenScript Expands Peptide and Oligonucleotide Production Facility in China
May 19, 2023
GenScript's new life-science building in Zhenjiang, Jiangsu, China spans 91,310 sq. ft. and is ISO 9001 certified; highly automated clean-room facilities offer fast-turnaround, high-purity oligonucleotide and peptide synthesis service for R&D and preclinical applications PISCATAWAY, N.J. -- GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, has expanded its primary manufacturing facility for oligonucleotide and [...]
Bionter Announces Partnership Agreement with Midwest Biosolutions to drive market growth in the US
May 19, 2023
Basel, Switzerland – Bionter, an innovative analytical technology provider, is excited to announce its partnership agreement with Midwest BioSolutions, a prominent sales agency in the US market. The collaboration aims to drive market growth and expand the reach of Bionter’s products and services in the Biopharma industry in the US. Through this partnership, Midwest Bio [...]
Caron Products Names Sebastian Scott Director of Global Supply Management
May 19, 2023
Caron continues its global expansion in the Life Science market MARIETTA, Ohio -- Today, Caron Products and Services, Inc. ("Caron"), a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell, and gene therapy research, and academic research, announced that Sebastian Scott has joined Caron's Leadership Team as Director of Global Supply [...]
May 19, 2023
New manufacturing facility and expanded capabilities will enable Singapore’s science and technology sector to accelerate research, development and manufacturing of critical medicines and vaccines WALTHAM, Mass. & SINGAPORE -- Thermo Fisher Scientific, the world leader in serving science, has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines [...]
Landmark Victory: KPM Analytics Prevails in Trade Secret Misappropriation Trial
May 19, 2023
Westborough, MA – KPM Analytics, a global leader in scientific instrumentation and machinery, focused primarily on analyzing critical quality parameters in the food and agricultural industries, is gratified to announce a resounding victory in a recent jury trial concerning trade secret misappropriation claims. In the United States District Court, the jury, after an extensive examination of [...]
Agilent to Appeal Patent Office Decision on CRISPR gRNA Patents
May 18, 2023
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A), announced today the company intends to appeal the U.S. Patent and Trademarks Office (USPTO) Patent Trial and Appeal Board’s (PTAB) Final Written Decision in connection with the Inter Partes review (IPR) of U.S. Patent Nos. 10,337,001 & 10,900,034 (the Agilent Patents). The PTAB recently reversed the USPTO’s [...]
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
May 18, 2023
New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated Molecular Biology Workstation SAN DIEGO -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its BioXp® NGS Library Prep kit [...]
Revvity Announces New License Agreement for Next-Generation Base Editing Technology
May 18, 2023
Non-exclusive agreement provides AstraZeneca access to proprietary gene editing technology to help advance its work in cell therapy WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY), today announced a new license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for the technology underlying its Pin-point™ base editing system, a next-generation modular gene editing platform with a strong safety profile. Dr. Alan [...]
May 18, 2023
HUNTSVILLE, Ala. -- Discovery Life Sciences™ (Discovery), the Biospecimen and Biomarker Specialists™, announced today that it has officially qualified as one of Akoya Biosciences' global service providers. The qualification process evaluated Discovery's proficiency in staining, imaging, and analysis―allowing the company to deliver comprehensive spatial imaging services to researchers across discovery, translational, and clinical research. With this qualification, [...]

